NYSE:SQZ SQZ Biotechnologies (SQZ) Stock Price, News & Analysis $0.02 0.00 (0.00%) As of 11/17/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFinancialsSEC Filings About SQZ Biotechnologies Stock (NYSE:SQZ) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SQZ Biotechnologies alerts:Sign Up Key Stats Today's Range$0.02▼$0.0250-Day Range$0.02▼$0.0252-Week Range$0.25▼$3.56Volume5 shsAverage Volume455,220 shsMarket Capitalization$707.78 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview SQZ Biotechnologies was a U.S.-based biotechnology company that developed cell therapies using its proprietary Cell Squeeze platform. The technology uses microfluidic devices to briefly deform cells, allowing therapeutic materials to enter them without relying on viral delivery methods. The company’s research focused on harnessing the immune system to treat cancer and other diseases. Its clinical programs included experimental cell therapies designed to generate immune responses against cancers associated with human papillomavirus (HPV). In late 2023, SQZ Biotechnologies filed for Chapter 11 bankruptcy protection and began winding down its operations. Its description as a biotechnology company reflects its historical business activities.AI Generated. May Contain Errors. Read More Receive SQZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SQZ Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SQZ Stock News HeadlinesSQZ Biotechnologies consensus price target decreased by 50.00% to $22.44November 2, 2026 | msn.comSQZ Biotechnologies Co.August 12, 2026 | barrons.comYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.November 18 at 1:00 AM | Reagan Gold Group (Ad)Arsenal Yards attracts another life sciences tenantApril 23, 2026 | bizjournals.comSQZB SQZ Biotechnologies Company - Seeking AlphaJuly 9, 2025 | seekingalpha.comSQZ Biotechnologies Co Ordinary SharesDecember 23, 2024 | morningstar.comMPortal Biotechnologies Announces Over 50 Partnerships and Oversubscribed $7M Seed Round Led by IA VenturesDecember 19, 2024 | finance.yahoo.comWhat is the price tag to keep the biotech engine humming in Massachusetts?July 23, 2024 | msn.comSee More Headlines SQZ Stock Analysis - Frequently Asked Questions How have SQZ shares performed this year? SQZ Biotechnologies' stock was trading at $0.0240 at the beginning of 2026. Since then, SQZ shares have increased by 0.0% and is now trading at $0.0240. How were SQZ Biotechnologies' earnings last quarter? SQZ Biotechnologies (NYSE:SQZ) released its quarterly earnings results on Wednesday, November, 10th. The company reported ($8.00) EPS for the quarter, missing analysts' consensus estimates of ($5.60) by $2.40. The company had revenue of $4.76 million for the quarter, compared to the consensus estimate of $11.64 million. SQZ Biotechnologies had a negative net margin of 369.96% and a negative trailing twelve-month return on equity of 119.83%. When did SQZ Biotechnologies' stock split? SQZ Biotechnologies's stock reverse split on Friday, July 7th 2023.The 1-10 reverse split was announced on Friday, July 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. When did SQZ Biotechnologies IPO? SQZ Biotechnologies (SQZ) raised $75 million in an initial public offering (IPO) on Friday, October 30th 2020. The company issued 4,400,000 shares at $16.00-$18.00 per share. BofA Securities and Stifel acted as the underwriters for the IPO and BTIG was co-manager. How do I buy shares of SQZ Biotechnologies? Shares of SQZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of SQZ Biotechnologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that SQZ Biotechnologies investors own include Adicet Bio (ACET), Agenus (AGEN), Aldeyra Therapeutics (ALDX), Allogene Therapeutics (ALLO), Athersys (ATHX), Atossa Genetics (ATOS) and Atea Pharmaceuticals (AVIR). Company Calendar Today11/18/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNYSE:SQZ CIK1604477 Webwww.sqzbiotech.com Phone617-758-8672FaxN/AEmployees1,620Year Founded2013Profitability EPS (Trailing Twelve Months)($2.61) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$79.46 million Net Margins-369.96% Pretax Margin-408.99% Return on Equity-119.83% Return on Assets-59.90% Debt Debt-to-Equity RatioN/A Current Ratio3.50 Quick Ratio3.50 Sales & Book Value Annual Sales$18.16 million Price / Sales0.04 Cash FlowN/A Price / Cash FlowN/A Book Value$1.94 per share Price / Book0.01Miscellaneous Outstanding Shares29,491,000Free Float24,772,000Market Cap$707.78 thousand OptionableNot Optionable Beta2.34 Social Links The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NYSE:SQZ) was last updated on 11/17/2026 by MarketBeat.com Staff. From Our PartnersEarly bird access on this Black Friday dealMarkham Trading's Alpha Oracle Signal system is just $7 for Black Friday. Others paid nearly $2,000 for access...TradeWins | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredChase, Wells Fargo and Capital One all showed errors on Nov. 16On November 16, customers of Chase, Bank of America, Wells Fargo, Capital One and Zelle reported errors when t...Cedar Gold Group | SponsoredYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SQZ Biotechnologies Please log in to your account or sign up in order to add this asset to your watchlist. Share SQZ Biotechnologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.